Back to UBS Group AG UBS Group AG

LYRALYRA
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in LYRA THERAPEUTICS INC

UBS Group AG previously held 0 shares of LYRA (LYRA THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$18

Total Shares Change

-2

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.24
0
2025-Q4
Decreased
675
-83.1%
$2,0790.0%$3.20
0
2025-Q3
Increased
4,001
+2000x
$26,1110.0%$6.50
21
2025-Q2
New
2
-
$180.0%$9.11
17

Other major holders of LYRA: VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used